BRCA2 and breast cancer: AZD2281 induced significant autophagy (37 and 44%) in BRCA1 mutant SUM-149PT and BRCA2 mutant HCC-1428 breast cancer breast cancers, respectively, in 24 of treatment (Fig. 3a).